Keynumbers for: IDL Biotech

 12/31/20106/30/201112/31/20116/30/201212/31/20126/30/201312/31/20136/30/2014
Number of months that the report spans126126126126
Total revenue (MSEK)16.497.8515.339.1817.4510.8922.4012.55
Earnings before interest and taxes (EBIT) (MSEK)-2.24-0.60-3.39-2.14-5.48-1.47-1.87-0.71
Pre tax profit (PTP) (MSEK)2.24-1.03-3.52-2.23-5.58-1.56-2.10-0.89
Net Revenue (MSEK)-2.34-1.13-3.52-2.23-5.58-1.56-2.10-0.89
Earnings per share (SEK)-0.12-0.06-0.18-0.12-0.24-0.06-0.08-0.03
Dividend per share (SEK)--------
Owner's equity (MSEK)4.828.706.3010.567.215.655.114.22
Fixed assets (MSEK)5.355.315.295.385.415.426.171.34
Intangible assets (MSEK)--4.684.885.025.144.754.65
Liquid assets (MSEK)7.038.358.1110.068.059.2811.3411.38
Total shareholder equity and liabilities (MSEK)-13.6613.3915.4413.4614.7017.5117.38
Long time debts including distributions (MSEK)0.290.220.150.08--0.750.67
Short term debt (MSEK)7.274.756.954.806.259.0511.6412.48
The share's par value (SEK)0.800.400.400.40.40.400.400.40
Cash flow for the period (MSEK)-0.100.46-47.35-0.15-0.170.65-0.58
Number of shares (in millions)-19 057 04319 057 04319 057 04327 338 18927 338 18927 338 18927 338 189
Average number of employees1111121113121112

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se